FDA signals uptick in enforcement with market sweep on depression claims
By EsqSocial Corporation 25/02/21
On 19 February, 2021 the U.S. Food and Drug Administration (FDA) announced warning letters to ten companies for selling dietary supplements that claim to cure, treat, mitigate, or prevent depression and other mental health disorders in violation of the Federal Food, Drug, and Cosmetic Act....
By: Hogan Lovells